Skip to main navigation Skip to search Skip to main content

Abstract

The absence of expression of the p16(INK4a) gene product is observed in virtually all mesothelioma tumors and cell lines, whereas wild-type pRB expression is maintained. We have examined the potential therapeutic role of re-expressing the p16(INK4a) gene product in mice with established human mesothelioma xenografts. Experiments using Adp16 treatments in mesothelioma xenografts demonstrated prolonged survival and potential cure following treatment with p16(INK4a)-based gene therapy. These results demonstrate that p16(INK4a) gene transfer may play a therapeutic role in the treatment of mesothelioma.

Original languageEnglish
Pages (from-to)1421-1425
Number of pages5
JournalCancer gene therapy
Volume7
Issue number11
DOIs
StatePublished - 2000

Keywords

  • Cell cycle
  • Gene therapy
  • Mesothelioma
  • Tumor suppressor
  • p16(INK4a)

Fingerprint

Dive into the research topics of 'Gene therapy of established mesothelioma xenografts with recombinant p16(INK4a) adenovirus'. Together they form a unique fingerprint.

Cite this